TABLE 2.
Demographics and Hippocampal Dentate Gyrus Pathology
| Characteristic/Pathology | Controls | FTLD-TDP A | FTLD-TDP B | FTLD-TDP C | FTLD-TDP D | HS | ALS/MND without Dementia |
|---|---|---|---|---|---|---|---|
| Mean age at death ± SD, yr | 81 ± 9 | 70 ± 4 | 66 ± 3 | 69 ± 8 | 47 | 88 ± 6 | 61 ± 14 |
| Sex, M:F | 6:9 | 4:2 | 5:1 | 5:7 | 1:0 | 5:4 | 4:1 |
| TDP-43-immunoreactive lesion cases, No. (%) | 2/15 (13%) | 6/6 (100%) | 6/6 (100%) | 12/12 (100%) | 1/1 (100%) | 8/9 (89%) | 2/5 (40%) |
| TDP-43 oligomer immunoreactive lesion cases, No. (%) | 1/15 (7%) | 3/6 (50%) | 4/6 (67%) | 12/12 (100%) | 0/1 (0%) | 0/9 (0%) | 2/5 (40%) |
ALS = amyotrophic lateral sclerosis; F = female; FTLD = frontotemporal lobar degeneration; HS = hippocampal sclerosis; M = male; MND = motor neuron disease; SD = standard deviation.